Literature DB >> 23039151

Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.

Orin Bloch1, Seunggu J Han, Soonmee Cha, Matthew Z Sun, Manish K Aghi, Michael W McDermott, Mitchel S Berger, Andrew T Parsa.   

Abstract

OBJECT: Extent of resection (EOR) has been shown to be an important prognostic factor for survival in patients undergoing initial resection of glioblastoma (GBM), but the significance of EOR at repeat craniotomy for recurrence remains unclear. In this study the authors investigate the impact of EOR at initial and repeat resection of GBM on overall survival.
METHODS: Medical records were reviewed for all patients undergoing craniotomy for GBM at the University of California San Francisco Medical Center from January 1, 2005, through August 15, 2009. Patients who had a second craniotomy for pathologically confirmed recurrence following radiation and chemotherapy were evaluated. Volumetric EOR was measured and classified as gross-total resection (GTR, > 95% by volume) or subtotal resection (STR, ≤ 95% by volume) after independent radiological review. Overall survival was compared between groups using univariate and multivariate analysis accounting for known prognostic factors, including age, eloquent location, Karnofsky Performance Status (KPS), and adjuvant therapies.
RESULTS: Multiple resections were performed in 107 patients. Fifty-two patients had initial GTR, of whom 31 (60%) had GTR at recurrence, with a median survival of 20.4 months (standard error [SE] 1.0 months), and 21 (40%) had STR at recurrence, with a median survival of 18.4 months (SE 0.5 months) (difference not statistically significant). Initial STR was performed in 55 patients, of whom 26 (47%) had GTR at recurrence, with a median survival of 19.0 months (SE 1.2 months), and 29 (53%) had STR, with a median survival of 15.9 months (SE 1.2 months) (p = 0.004). A Cox proportional hazards model was constructed demonstrating that age (HR 1.03, p = 0.004), KPS score at recurrence (HR 2.4, p = 0.02), and EOR at repeat resection (HR 0.62, p = 0.02) were independent predictors of survival. Extent of initial resection was not a statistically significant factor (p = 0.13) when repeat EOR was included in the model, suggesting that GTR at second craniotomy could overcome the effect of an initial STR.
CONCLUSIONS: Extent of resection at recurrence is an important predictor of overall survival. If GTR is achieved at recurrence, overall survival is maximized regardless of initial EOR, suggesting that patients with initial STR may benefit from surgery with a GTR at recurrence.

Entities:  

Mesh:

Year:  2012        PMID: 23039151     DOI: 10.3171/2012.9.JNS12504

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  107 in total

Review 1.  Optimizing glioblastoma resection: intraoperative mapping and beyond.

Authors:  Joseph A Osorio; Manish K Aghi
Journal:  CNS Oncol       Date:  2014

2.  Sensitivity analysis aimed at blood vessels detection using interstitial optical tomography during brain needle biopsy procedures.

Authors:  Julien Pichette; Andréanne Goyette; Fabien Picot; Marie-Andrée Tremblay; Gilles Soulez; Brian C Wilson; Frédéric Leblond
Journal:  Biomed Opt Express       Date:  2015-10-05       Impact factor: 3.732

3.  Minimally invasive resection of intracranial lesions using tubular retractors: a large, multi-surgeon, multi-institutional series.

Authors:  Daniel G Eichberg; Long Di; Ashish H Shah; Evan M Luther; Christina Jackson; Lina Marenco-Hillembrand; Kaisorn L Chaichana; Michael E Ivan; Robert M Starke; Ricardo J Komotar
Journal:  J Neurooncol       Date:  2020-06-18       Impact factor: 4.130

4.  Polymalic acid chlorotoxin nanoconjugate for near-infrared fluorescence guided resection of glioblastoma multiforme.

Authors:  Rameshwar Patil; Anna Galstyan; Tao Sun; Ekaterina S Shatalova; Pramod Butte; Adam N Mamelak; Christine Carico; David S Kittle; Zachary B Grodzinski; Antonella Chiechi; Hui Ding; Keith L Black; Julia Y Ljubimova; Eggehard Holler
Journal:  Biomaterials       Date:  2019-03-23       Impact factor: 12.479

5.  The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.

Authors:  Debra A Goldman; Koos Hovinga; Anne S Reiner; Yoshua Esquenazi; Viviane Tabar; Katherine S Panageas
Journal:  J Neurosurg       Date:  2018-11-01       Impact factor: 5.115

6.  Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.

Authors:  Joshua D Palmer; Joshua Siglin; Kosj Yamoah; Tu Dan; Colin E Champ; Voichita Bar-Ad; Maria Werner-Wasik; James J Evans; Lyndon Kim; Jon Glass; Christopher Farrell; David W Andrews; Wenyin Shi
Journal:  J Neurooncol       Date:  2015-05-30       Impact factor: 4.130

7.  Re-do craniotomy for recurrent glioblastoma.

Authors:  Ahmed A Morsy; Wai Hoe Ng
Journal:  CNS Oncol       Date:  2015

Review 8.  Treatment options for recurrent high-grade gliomas.

Authors:  Harjus S Birk; Seunggu J Han; Nicholas A Butowski
Journal:  CNS Oncol       Date:  2016-12-21

9.  Surgical treatment of glioblastoma in the elderly: the impact of complications.

Authors:  Michael Karsy; Nam Yoon; Lillian Boettcher; Randy Jensen; Lubdha Shah; Joel MacDonald; Sarah T Menacho
Journal:  J Neurooncol       Date:  2018-02-01       Impact factor: 4.130

Review 10.  Glioblastoma: Overview of Disease and Treatment.

Authors:  Mary Elizabeth Davis
Journal:  Clin J Oncol Nurs       Date:  2016-10-01       Impact factor: 1.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.